1. Home
  2. Analysis
  3. Alprazolam
  4. Stromectol

Alprazolam and Stromectol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alprazolam (alprazolam) and Stromectol (ivermectin). Common drug interactions include rash among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Alprazolam and Stromectol. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Alprazolam?

Alprazolam has active ingredients of alprazolam. It is often used in stress and anxiety. eHealthMe is studying from 134,864 Alprazolam users. Check the latest studies of Alprazolam.

What is Stromectol?

Stromectol has active ingredients of ivermectin. eHealthMe is studying from 3,361 Stromectol users. Check the latest studies of Stromectol.

On Jul, 11, 2026

25 people who take Alprazolam and Stromectol together, and have interactions are studied.

Alprazolam and Stromectol drug interactions.

What are the common drug interactions of Alprazolam and Stromectol, by gender? *:

female:

  1. Rash
  2. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  3. Renal failure (kidney dysfunction)
  4. Chronic kidney disease
  5. Altered state of consciousness (altered state of mind)
  6. Death
  7. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  8. Hepatitis (inflammation of the liver)
  9. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  10. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)

male:

  1. Chronic kidney disease
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Drug ineffective
  4. Infection parasitic
  5. Renal failure (kidney dysfunction)

What are the common drug interactions of Alprazolam and Stromectol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  2. Chronic kidney disease
  3. Hepatitis (inflammation of the liver)
  4. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  5. Renal failure (kidney dysfunction)

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)

50-59:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Altered state of consciousness (altered state of mind)

60+:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Cheilitis (infection of lips)
  3. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  4. Nephrogenic anaemia (anaemia due to kidney disease)
  5. Pruritus (severe itching of the skin)
  6. Renal injury (kidney injury)
  7. Septic shock (shock due to blood infection)
  8. Urinary tract infection
  9. Conjunctivitis (pink eye)
  10. Diarrhoea

What are the existing conditions these people have? *

  1. Acarodermatitis (skin inflammation caused by mites (acarids)): 12 people, 48.00%
  2. Type 2 Diabetes: 11 people, 44.00%
  3. Pemphigoid (tense blisters on the skin): 10 people, 40.00%
  4. Gastritis (inflammation of stomach): 10 people, 40.00%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 10 people, 40.00%
  6. High Blood Pressure: 4 people, 16.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.00%
  8. Infection: 3 people, 12.00%
  9. High Blood Cholesterol: 3 people, 12.00%
  10. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Alprazolam and Stromectol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alprazolam and Stromectol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alprazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Stromectol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alprazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Stromectol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on alprazolam and ivermectin (the active ingredients of Alprazolam and Stromectol, respectively), and Alprazolam and Stromectol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.